Share this article
SALT LAKE CITY, Feb. 23, 2021 /PRNewswire/
Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced today that it is pleased to welcome Brian Brown, CPA to the position of Co-Diagnostics Chief Financial Officer ( CFO ). Dr. Jesse Montgomery, PhD has also been elevated to the role of Chief Scientific Officer ( CSO ). Reed Benson, former CFO, will remain with the Company as general counsel, and Dr. Brent Satterfield, founder and former CSO, will continue his involvement with Co-Diagnostics as Head of the Scientific Advisory Board.
Following significant growth in the past year and in anticipation of additional growth in the future, the Company has elected to add additional resources to its financial department. Mr. Brown s previous experience includes CFO, Vice President of Accounting & Investor Relations, and Director of Finance roles for public and private companie